PRESENTIA NIPD GENETICS HEREDITARY CANCER Trademark

Trademark Overview


On Monday, December 23, 2019, a trademark application was filed for PRESENTIA NIPD GENETICS HEREDITARY CANCER with the United States Patent and Trademark Office. The USPTO has given the PRESENTIA NIPD GENETICS HEREDITARY CANCER trademark a serial number of 79279811. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by NIPD Genetics Public Company Limited. The PRESENTIA NIPD GENETICS HEREDITARY CANCER trademark is filed in the Chemical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Kits and reagents for genetic testing for medical and scientific research purposes in the field of cancer detection; kits and reagents for cancer testing for medical and scientific research purposes; nucleic acid based kits and reagents for testing cancer diseases for medical and scientific research purposes

Medical analysis services for the diagnosis and prognosis of cancer; medical genetic testing services for diagnosis, prevention and treatment of cancer; medical testing of blood for diagnosis of cancer; genetic testing and genetic counseling in the field of cancer detection; medical and health services relating to DNA and genetics testing; RNA and DNA analysis for cancer diagnosis and prognosis

Medical laboratory services for testing of cancer and cancer prevention; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of cancer detection; genetic engineering services, namely, scientific research in the field of genetic engineering; scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of nucleic acid analysis, cancer testing, and genetics; scientific research for medical purposes in the field of cancerous diseases
presentia nipd genetics hereditary cancer

General Information


Serial Number79279811
Word MarkPRESENTIA NIPD GENETICS HEREDITARY CANCER
Filing DateMonday, December 23, 2019
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6160909
Registration DateTuesday, September 29, 2020
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements


Description of MarkThe mark consists of three lines of stylized wording. The first line is "NIPD GENETICS" in gray in stylized form. The second line is "PRESENTIA" in stylized form, where "PRE" is in yellow, and "SENTIA" is in gray. The third line is "HEREDITARY CANCER" in yellow.
Indication of Colors claimedThe color(s) yellow and grey is/are claimed as a feature of the mark.
Goods and ServicesKits and reagents for genetic testing for medical and scientific research purposes in the field of cancer detection; kits and reagents for cancer testing for medical and scientific research purposes; nucleic acid based kits and reagents for testing cancer diseases for medical and scientific research purposes
Translation of Words in MarkThe English translation of "PRESENTIA" in the mark is "TO SENSE".
Goods and ServicesMedical analysis services for the diagnosis and prognosis of cancer; medical genetic testing services for diagnosis, prevention and treatment of cancer; medical testing of blood for diagnosis of cancer; genetic testing and genetic counseling in the field of cancer detection; medical and health services relating to DNA and genetics testing; RNA and DNA analysis for cancer diagnosis and prognosis
Disclaimer with Predetermined Text"NIPD GENETICS" AND "HEREDITARY CANCER"
Goods and ServicesMedical laboratory services for testing of cancer and cancer prevention; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of cancer detection; genetic engineering services, namely, scientific research in the field of genetic engineering; scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of nucleic acid analysis, cancer testing, and genetics; scientific research for medical purposes in the field of cancerous diseases

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMEDICOVER PUBLIC CO LTD
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCY

Party NameNIPD Genetics Public Company Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCY

Party NameNIPD Genetics Public Company Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCY

Trademark Events


Event DateEvent Description
Wednesday, June 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 2, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, October 29, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 15, 2021GENERIC MADRID TRANSACTION SENT TO IB
Friday, January 15, 2021GENERIC MADRID TRANSACTION CREATED
Tuesday, December 29, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 26, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 26, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 26, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 26, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 26, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 24, 2020REFUSAL PROCESSED BY IB
Wednesday, April 8, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 8, 2020REFUSAL PROCESSED BY MPU
Friday, March 20, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 19, 2020NON-FINAL ACTION WRITTEN
Thursday, March 19, 2020ASSIGNED TO EXAMINER
Friday, March 6, 2020APPLICATION FILING RECEIPT MAILED
Monday, March 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 27, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB